Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area jak stat signaling egfr'

Search results for: 'research area jak stat signaling egfr'

Items 1-10 of 121

Page
per page
  1. Cucurbitacin I
    A4512 Cucurbitacin I
    Target: STAT|JAK
    Summary: STAT3/JAK2 signaling inhibitor
      ≥22.45 mg/mL
  2. WP1066
    A4140 WP1066
    Target: STAT|JAK
    Summary: JAK2/STAT3 inhibitor,cell-permeable
      insoluble in H2O; ≥17.8 mg/mL
  3. Pyridone 6
    A3741 Pyridone 6
    Target: JAK
    Summary: Pan-JAK inhibitor
      insoluble in H2O; ≥15.45 mg/mL
  4. Fludarabine Phosphate (Fludara)
    A8317 Fludarabine Phosphate (Fludara)
     2 Citation
    Target: STAT
    Summary: Inhibits STAT1 activation and DNA synthesis
      insoluble in EtOH; ≥17.6 mg/mL
  5. Fludarabine
    A5424 Fludarabine
    Summary: DNA synthsis inhibitor
      insoluble in H2O; insoluble in EtOH; ≥9.25 mg/mL
  6. Lapatinib Ditosylate
    A3967 Lapatinib Ditosylate
    Target: EGFR|ErbB-2
    Summary: EGFR/HER2 inhibitor,potent and selective
      ≥24.3 mg/mL
  7. AG-490
    A4139 AG-490
     3 Citation
    Target: EGFR|JAK
    Summary: JAK2/EGFR inhibitor
      insoluble in H2O; ≥14.7 mg/mL
  8. Gefitinib (ZD1839)
    A8219 Gefitinib (ZD1839)
     3 Citation
    Target: EGFR
    Summary: Selective EGFR inhibitor
      ≥22.34 mg/mL
  9. Lapatinib
    A8218 Lapatinib
     2 Citation
    Target: ErbB
    Summary: EGFR/HER2 inhibitor,potent,selective and reversible
      ≥29.05 mg/mL
  10. Tofacitinib (CP-690550) Citrate
    A4135 Tofacitinib (CP-690550) Citrate
     2 Citation
    Target: JAK
    Summary: Potent JAK inhibitor
      ≥25.22 mg/mL

Items 1-10 of 121

Page
per page
Shop By
Now Shopping by
  1. Reported Experiments Cell Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 118item
  2. Natural Products 1 item
  3. Protein 2item
  4. Peptides & Proteins 3item
Specificity
  1. Selective 63item
  2. Non-Selective 1 item
Reversibility
  1. Reversible 3item
  2. Irreversible 4item
Target
  1. Cyclin-Dependent Kinases 1 item
  2. Histone Deacetylases (HDACs) 1 item
  3. Akt 7item
  4. PI3K 11item
  5. Raf 6item
  6. Aurora Kinases 1 item
  7. mTOR 6item
  8. Androgen Receptors 1 item
  9. FLT3 2item
  10. GSK-3 4item
  11. VEGFR 6item
  12. PDGFR 3item
  13. Phosphodiesterases (PDEs) 1 item
  14. p38 4item
  15. PKB 1 item
  16. Bcr-Abl 1 item
  17. MEK 3item
  18. PORCN 1 item
  19. FGFR 3item
  20. GABAB Receptors 1 item
  21. MET 1 item
  22. Src 2item
  23. Trk Receptors 1 item
  24. NMDA Receptors 1 item
  25. STAT 5item
  26. EGFR 17item
  27. JAK 15item
  28. Syk 1 item
  29. DNA-PK 1 item
  30. HSP90 1 item
  31. ErbB 4item
  32. Toll-like receptors (TLRs) 1 item
  33. ERK 2item
  34. c-MET 1 item
  35. PKC 6item
  36. HER2 1 item
  37. ALK 2item
  38. PKG 1 item
  39. PKA 3item
  40. RSK 1 item
  41. Histamine H1 Receptors 1 item
  42. MNK 1 item
  43. NO Donors / Precursors 1 item
  44. IL Receptors 1 item
  45. AChE 1 item
  46. Insulin Receptors 1 item
  47. IRG-1R 1 item
  48. BACE 1 item
  49. c-RET 1 item
  50. p70 rsk 1 item
  51. sodium channels 1 item
  52. insulin 1 item
  53. Smoothened receptor 1 item
  54. Nrf2/ARE signal 1 item
  55. PPAR 1 item
  56. Antibiotic 1 item
  57. ErbB-2 1 item
  58. Prk 1 item
  59. ICAM 1 item
  60. Rho 1 item
  61. TYK2 2item
  62. MUSK 1 item
  63. MAP3K 1 item
  64. Thrombin Receptor 1 item
  65. prolactin secretion 1 item
  66. gonadotropin release 1 item
  67. TRPC channel 1 item
  68. FKBP 1 item
Related Disease
  1. Acute Myelogenous Leukemia 1 item
  2. Acute Myeloid Leukemia 3item
  3. Bladder Cancer 2item
  4. Breast Cancer 18item
  5. Cancer 70item
  6. Cervical Cancer 1 item
  7. Colon Cancer 7item
  8. Colorectal Cancer 8item
  9. Glioblastoma 9item
  10. Glioma 3item
  11. Heart Failure 1 item
  12. Hepatocellular Carcinoma 1 item
  13. HIV Infections 1 item
  14. Leukemia 8item
  15. Liver Cancer 2item
  16. Lung Cancer 4item
  17. Lymphoma 3item
  18. Melanoma 5item
  19. Multiple Myeloma 1 item
  20. Myelofibrosis 1 item
  21. Myeloma 1 item
  22. Neuroblastoma 1 item
  23. Non-small Cell Lung Cancer 4item
  24. Ovarian Cancer 6item
  25. Pancreatic Cancer 8item
  26. Pancreatic Carcinoma 1 item
  27. Prostate Cancer 10item
  28. Psoriasis 1 item
  29. Pulmonary Fibrosis 1 item
  30. Renal Cell Carcinoma 1 item
  31. Rheumatoid Arthritis 3item
  32. Thyroid Cancer 2item
  33. Type 2 Diabetes 1 item